【近5年著作】

Tsai HC, Liao HT, Tsai CY. Retroperitoneal Fibrosis With a Damaged Kidney in IgG4-Related Disease. J Clin Rheumatol. 2019 Oct 22. doi: 10.1097/RHU.0000000000001181

Tsai HC, Chang FP, Li TH, Liu CW, Huang CC, Huang SF, Yang YY, Lee KC, Hsieh YC, Wang YW, Lee TY, Huang YH, Hou MC, Lin HC. Elafibranor Inhibits Chronic Kidney Disease Progression in NASH Mice. Biomed Res Int. 2019 Jun 19;2019:6740616. doi: 10.1155/2019/6740616

Tsai HC, Li TH, Huang CC, Huang SF, Liu RS, Yang YY, Hsieh YC, Lee KC, Huang YH, Hou MC, Lin HC. Beneficial Effects of the Peroxisome Proliferator-Activated Receptor α/γ Agonist Aleglitazar on Progressive Hepatic and Splanchnic Abnormalities in Cirrhotic Rats with Portal Hypertension.
Am J Pathol. 2018 Jul;188(7):1608-1624. doi: 10.1016/j.ajpath.2018.03.018. Epub 2018 Jun 19. Erratum in: Am J Pathol. 2018 Sep;188(9):2139.

Hung-Cheng Tsai, Chien-Fu Hsu, Chia-Chang Huang, Shiang-Fen Huang, Tzu-Hao Li, Ying-Ying Yang, Ming-Wei Lin, Tzung-Yan Lee, Chih-Wei Liu, Yi-Hsiang Huang, Ming-Chih Hou, Han-Chieh Lin. Propranolol Suppresses the T-Helper Cell Depletion-Related Immune Dysfunction in Cirrhotic Mice. Cells. 2020 Mar 3;9(3):604. doi: 10.3390/cells9030604. PMID: 32138352; PMCID: PMC7140430.

Tsai HC, Yang YY. Pioglitazone decrease intrapulmonary shunt in biliary cirrhotic rats with hepatopulmonary syndrome. J Chin Med Assoc. 2017 Nov;80(11):679-680. doi: 10.1016/j.jcma.2017.08.005. Epub 2017 Sep 24. No abstract available.